Bharat Rasayan Ltd

Bharat Rasayan Ltd

₹ 1,489 2.66%
27 May - close price
About

Bharat Rasayan Ltd is engaged in manufacturing Technical Grade Pesticides and Intermediates used in the agro-chemical industry. It was incorporated in 1989.[1]

Key Points

Product Portfolio
The company has a leading market position in many technical and intermediate products, including Lambda Cyhalothrin Technical, Metaphenoxy Benzaldehyde, Metribuzine Technical, Thiamethoxam (Insecticides), Fipronil (Insecticides), etc. It has also added new products like Fluxametamide, Tolfenpyrad Technical, Diuron Technical, etc. Top 10 products account for 66% of total sales. [1]

  • Market Cap 2,474 Cr.
  • Current Price 1,489
  • High / Low 3,030 / 1,202
  • Stock P/E 15.5
  • Book Value 767
  • Dividend Yield 0.03 %
  • ROCE 17.4 %
  • ROE 13.3 %
  • Face Value 5.00

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • The company has delivered a poor sales growth of 2.62% over past five years.
  • Company has a low return on equity of 11.9% over last 3 years.
  • Dividend payout has been low at 0.37% of profits over last 3 years

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
306 239 263 233 310 282 328 256 307 377 286 270 308
249 234 250 207 240 244 281 215 270 308 253 228 259
Operating Profit 56 6 13 26 69 38 47 42 37 69 33 43 49
OPM % 18% 2% 5% 11% 22% 14% 14% 16% 12% 18% 12% 16% 16%
-3 9 4 4 22 22 7 18 6 -8 11 17 10
Interest 1 0 1 1 1 1 1 1 1 1 1 1 1
Depreciation 6 6 6 7 6 6 6 7 7 6 6 7 7
Profit before tax 46 8 10 22 84 53 46 52 35 54 36 52 51
Tax % 34% 8% 39% 29% 20% 19% 30% 21% 27% 26% 23% 23% 26%
30 7 6 15 67 43 32 41 25 40 28 40 38
EPS in Rs 18.22 4.27 3.61 9.22 40.43 25.98 19.36 24.42 15.14 23.89 16.80 24.08 22.95
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
989 1,213 1,091 1,301 1,234 1,044 1,171 1,242
802 983 852 1,050 1,043 926 996 1,043
Operating Profit 188 230 240 250 191 118 175 199
OPM % 19% 19% 22% 19% 15% 11% 15% 16%
1 14 6 16 15 35 42 25
Interest 16 16 4 7 6 3 5 5
Depreciation 17 22 26 25 26 26 27 26
Profit before tax 155 205 215 234 174 123 185 193
Tax % 28% 23% 24% 25% 28% 23% 24% 25%
112 158 164 176 125 96 141 146
EPS in Rs 65.60 92.73 96.39 106.01 75.07 57.54 84.89 87.67
Dividend Payout % 1% 0% 0% 0% 0% 1% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 3%
3 Years: 0%
TTM: 6%
Compounded Profit Growth
10 Years: %
5 Years: -1%
3 Years: 8%
TTM: 22%
Stock Price CAGR
10 Years: 19%
5 Years: -14%
3 Years: -17%
1 Year: -33%
Return on Equity
10 Years: %
5 Years: 14%
3 Years: 12%
Last Year: 13%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 4 4 4 4 4 4 4 8
Reserves 405 560 723 766 889 984 1,126 1,266
247 94 58 174 28 80 85 1
100 94 122 142 152 129 193 157
Total Liabilities 756 752 908 1,086 1,074 1,197 1,408 1,433
150 203 191 228 225 230 230 246
CWIP 35 18 18 11 11 6 15 46
Investments 0 9 150 43 67 143 298 324
570 522 549 803 771 818 865 816
Total Assets 756 752 908 1,086 1,074 1,197 1,408 1,433

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
-52 263 170 -65 213 41 172 132
-46 -53 -149 64 -43 -76 -148 -96
102 -169 -40 -25 -152 49 -1 -89
Net Cash Flow 4 40 -19 -26 18 14 23 -53
Free Cash Flow -100 204 160 -121 191 14 137 59
CFO/OP -5% 137% 92% -3% 138% 59% 120% 88%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 103 75 99 130 96 138 131 113
Inventory Days 112 70 90 120 141 135 136 150
Days Payable 24 17 33 30 33 37 67 44
Cash Conversion Cycle 191 128 156 221 204 236 200 219
Working Capital Days 96 94 114 136 165 199 170 265
ROCE % 34% 31% 28% 20% 12% 16% 17%

Insights

In beta
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Geographic Reach - Number of Countries
Number ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Installed Capacity
MTPA ・Standalone data
Export Share of Total Sales
% ・Standalone data
Formulations Share of Sales
% ・Standalone data
Intermediates Share of Sales
% ・Standalone data
Technical Grade Pesticides Share of Sales
% ・Standalone data
Number of International Registrations
Number ・Standalone data
Number of Domestic Registrations
Number ・Standalone data
Top 10 Customers Share of Income
% ・Includes some standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99%
0.35% 0.35% 0.34% 0.34% 0.35% 0.46% 0.45% 0.49% 0.56% 0.47% 0.43% 0.54%
2.57% 2.57% 2.57% 2.57% 2.59% 2.64% 2.60% 2.75% 2.74% 2.75% 2.52% 2.14%
22.09% 22.09% 22.09% 22.09% 22.07% 21.90% 21.96% 21.77% 21.71% 21.79% 22.05% 22.33%
No. of Shareholders 16,36116,05915,39814,66715,15615,88915,85715,03615,66815,38821,33321,935

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents